Neomie Friedman, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 900 Washington Rd, Credentials Office, West Point, NY 10996 Phone: 845-938-3470 |
Dr. Stacey Jeanne Pappas, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 900 Washington Rd, West Point, NY 10996 Phone: 845-938-3003 |
Roman Greenspan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 900 Washington Rd, West Point, NY 10996 Phone: 845-938-4114 Fax: 845-938-1120 |
Dr. Marguerite Mary Mcguigan-shuster, MD Family Medicine - Sports Medicine Medicare: Medicare Enrolled Practice Location: 900 Washington Road, Keller Army Community Hospital, West Point, NY 10996 Phone: 845-938-7992 Fax: 360-475-4344 |
News Archive
Agilent Technologies Inc. (NYSE:A) and CambTEK, Ltd. today announced an agreement to co-market CambTEK's Rapid Extraction System (RES) automated sample preparation technology with an assortment of Agilent's liquid phase separation, life science and chemical analysis instruments and software.
Circuit Therapeutics today announced that it has been awarded a 2.7 million dollar contract from the Defense Advanced Research Projects Agency to pursue optogenetic therapies for peripheral nervous system indications. The award, part of DARPA's Electrical Prescriptions (ElectRX) program, will enable Circuit to pursue research and development projects related to its treatment for neuropathic pain.
Acutus Medical, Inc. (ACM), a medical device company developing a minimally invasive real-time 3D Cardiac Chamber Imaging and Dipole Density Mapping system to identify the sources that cause and / or sustain complex cardiac arrhythmias, including atrial fibrillation, announced it has completed an additional $26.2M financing to continue developing its imaging/mapping system as well as bring to market a complete product portfolio.
Scientists from the Florida campus of The Scripps Research Institute have been awarded a pair of grants totaling nearly $2.8 million from the National Institute of Allergy and Infectious Diseases of The National Institutes of Health to develop a new therapeutic agent to reduce latent levels of HIV that hide from the immune system in infected individuals.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that enrollment and treatment of patients in a Phase 1b clinical trial has been initiated to evaluate JX-594 in patients with advanced metastatic, refractory colorectal cancer (CRC).
› Verified 6 days ago